ST001312 Lipid expression in serum after early lifer exposure to an endocrine disruptor at 70 days postnatal (part-III) | ||||
Limit by pathway class: |
Pathway name (# of metabolites detected in this study) | HMDB pathway | KEGG pathway |
---|---|---|
Glycerolipid Metabolism (63) | SMP0000039 | map00561 |
Phosphatidylinositol Phosphate Metabolism (2) | SMP0000463 | map00562 |
Phospholipid Biosynthesis (141) | SMP0000025 | map00564 |
Plasmalogen Synthesis (3) | SMP0000479 | - |
Sphingolipid Metabolism (2) | SMP0000034 | map00600 |
Steroid Biosynthesis (3) | SMP0000023 | map00100 |